XML 54 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The following table summarizes the impact of all stock-based compensation expense on our Consolidated Statements of (Loss) Income for the years ended December 31, 2022, 2021, and 2020:

 

(in millions)

 

2022

 

2021

 

2020

Selling, general and administrative expense

$

9.5

$

15.2

$

6.5

Loss before income tax

 

(9.5)

 

(15.2)

 

(6.5)

Income tax benefit

 

(2.2)

 

(3.6)

 

(1.6)

Net loss

$

(7.3)

$

(11.6)

$

(4.9)

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan

Stock-based compensation expense by award type for the years ended December 31, 2022, 2021 and 2020 was as follows:

 

(in millions)

 

2022

 

2021

 

2020

Stock option compensation expense

$

3.7

$

3.6

$

2.7

RSU compensation expense

 

4.4

 

5.3

 

5.2

PSU compensation expense

 

1.4

 

6.3

 

(1.4)

Total stock-based compensation expense

$

9.5

$

15.2

$

6.5

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model and the weighted average assumptions as outlined in the following table:

 

 

 

Year Ended December 31,

 

 

2022

 

2021

 

2020

Weighted average expected lives

 

6.0 years

 

6.0 years

 

6.0 years

Weighted average risk-free interest rate

 

1.89 %

 

0.93 %

 

0.81 %

Weighted average expected volatility

 

41.7 %

 

41.3 %

 

36.0 %

Expected dividend yield

 

3.60 %

 

3.07 %

 

3.16 %

Weighted average grant date fair value

 

$2.43

 

$2.45

 

$2.03

Summary of Changes in Stock Options Outstanding

A summary of the changes in stock options outstanding under the Plan during the year ended December 31, 2022 is presented below:

 

 

 

Number
Outstanding

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2021

 

 

5,860,567

 

 

$

9.34

 

 

 

 

 

 

Granted

 

 

1,793,833

 

 

$

8.35

 

 

 

 

 

 

Exercised

 

 

(573,860

)

 

$

7.51

 

 

 

 

 

 

Forfeited

 

 

(351,925

)

 

$

8.59

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

6,728,615

 

 

$

9.27

 

 

6.1 years

 

 

- million

 

Exercisable shares at December 31, 2022

 

 

3,643,352

 

 

$

10.04

 

 

4.2 years

 

 

- million

 

Summary of Changes in RSUs Outstanding

A summary of the changes in the RSUs outstanding under the Plan during 2022 is presented below:

 

 

 

Stock
Units

 

 

Weighted Average Grant Date Fair Value

 

Outstanding at December 31, 2021

 

 

1,906,891

 

 

$

8.64

 

Granted

 

 

695,057

 

 

$

8.15

 

Vested and distributed

 

 

(489,964

)

 

$

8.86

 

Forfeited and cancelled

 

 

(95,864

)

 

$

8.25

 

Outstanding at December 31, 2022

 

 

2,016,120

 

 

$

8.43

 

Vested and deferred at December 31, 2022(1)

 

 

574,409

 

 

$

8.84

 

 

(1)
Included in outstanding at December 31, 2022. Vested and deferred RSUs are primarily related to deferred compensation for non-employee directors.
Summary of Changes in PSUs Outstanding

A summary of the changes in the PSUs outstanding under the Plan during 2022 is presented below:

 

 

 

Stock
Units

 

 

Weighted Average Grant Date Fair Value

 

Outstanding at December 31, 2021

 

 

1,758,220

 

 

$

8.42

 

Granted

 

 

1,170,884

 

 

$

8.88

 

Vested

 

 

(350,656

)

 

$

8.42

 

Forfeited and cancelled

 

 

(161,938

)

 

$

8.62

 

Other - decrease due to performance of PSUs

 

 

(1,743,341

)

 

$

8.71

 

Outstanding at December 31, 2022

 

 

673,169

 

 

$

8.42